Previous 10 | Next 10 |
2024-05-16 09:00:00 ET Summary The combination of earnings season and a dovish Fed are pushing the markets closer to all-time highs. The Dividend Harvesting Portfolio has reached an all-time high in profitability and account value, with a 13.14% return on invested capital. The...
2024-05-16 06:48:39 ET More on Roche Roche: Value Remains Despite Covid-19 Revenue Growth Loss Roche Holding AG (RHHBY) Q1 2024 Sales/Trading Statement Call Transcript Q1 2024 Sales/ Trading Statement Call J&J, Roche, AstraZeneca poised to have highest or...
– After six months of additional follow-up, clinical benefit rate (63%), overall response rate (41.9%), median progression-free survival (11.2 months), and safety profile of vepdegestrant in combination with palbociclib were consistent with data previously reported at SABCS in December 202...
2024-05-16 05:47:27 ET Pfizer ( NYSE: PFE ) will pay up to $250M to settle more than 10,000 U.S. lawsuits alleging that the company concealed cancer risks associated with its now-discontinued heartburn drug Zantac.... Read the full article on Seeking Alpha For further de...
2024-05-16 00:20:00 ET Summary Diamond Hill invests on behalf of clients through a shared commitment to its valuation-driven investment principles, long-term perspective, capacity discipline and client alignment. Our portfolio advanced double digits in Q1, outperforming the Russel...
2024-05-15 11:40:47 ET The temperament on Wall Street is mixed at the moment, split between analysts believing that the next leg up in a bull market is set to take place and others forecasting a bearish move lurking around the corner. For investors looking for more safety, dividend picks ca...
2024-05-15 08:45:36 ET Summary Pfizer has been a losing investment for several years, but stronger trading momentum is starting to appear. An easily covered and safety-minded 6% dividend yield is very attractive today. Undervaluation arguments to own shares also exist. PFE sto...
2024-05-14 10:07:00 ET Your long-term investment portfolio should have meaningful exposure to healthcare stocks . People will always seek treatments for disease, so demand for the sector won't go away any time soon. Moreover, there's a wide variety of healthcare companies, making it an ...
2024-05-14 08:10:00 ET Summary Portfolio changes in April focus on BDCs, aiming to increase dividend income by at least $100 each month. Dividend income hit a new all-time record for April of $736, basically flat Y/Y and up 12% sequentially. Gifted Working Time 2024: Around 85...
2024-05-13 13:53:13 ET More on AstraZeneca, Pfizer Pfizer's Bottom May Be Here - Its Rich Yield Is Tempting Pfizer: A 6% Yield And At 10-Year Lows Pfizer Stock: Not A Value Trap, Here's Why Pfizer to settle over 10,000 Zantac-related cancer claims: report ...
News, Short Squeeze, Breakout and More Instantly...
Giroctocogene fitelparvovec study meets primary and key secondary objectives of superiority compared to prophylaxis Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 3 AFFINE study ( NCT04370054 ) evaluating giroctocogene fitelparvovec, an investigation...
2024-07-22 05:59:00 ET Both Pfizer (NYSE: PFE) and Roche Holdings (OTC: RHHBY) rank among the world's most powerful pharmaceutical companies. Yet neither is actively competing in the all-important market for weight loss drugs, which is currently being split between the likes...
2024-07-20 10:00:00 ET On July 11, Pfizer (NYSE: PFE) made an announcement that came as a bit of a surprise to biopharma industry experts and Wall Street analysts alike. It's planning on advancing one of its early-stage weight loss programs into mid-stage trials. In due time, the mo...